Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2009 1
2010 2
2011 6
2012 2
2013 1
2014 1
2016 2
2017 1
2018 1
2019 2
2020 6
2021 3
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome.
Blatnik A, Ribnikar D, Šetrajčič Dragoš V, Novaković S, Stegel V, Grčar Kuzmanov B, Boc N, Perić B, Škerl P, Klančar G, Krajc M. Blatnik A, et al. Among authors: stegel v. Breast Cancer. 2022 Sep;29(5):921-927. doi: 10.1007/s12282-022-01354-0. Epub 2022 Apr 5. Breast Cancer. 2022. PMID: 35381901 Free PMC article.
Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high-grade serous carcinoma from ascites.
Miceska S, Škof E, Novaković S, Stegel V, Jeričević A, Grčar Kuzmanov B, Smrkolj Š, Cvjetičanin B, Bebar S, Globočnik Kukovica M, Kloboves-Prevodnik V. Miceska S, et al. Among authors: stegel v. Cancer Cytopathol. 2023 Mar;131(3):188-197. doi: 10.1002/cncy.22664. Epub 2022 Nov 18. Cancer Cytopathol. 2023. PMID: 36399410 Free article.
Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing.
Stegel V, Blatnik A, Škof E, Dragoš VŠ, Krajc M, Gregorič B, Škerl P, Strojnik K, Klančar G, Banjac M, Žgajnar J, Ravnik M, Novaković S. Stegel V, et al. Cancers (Basel). 2022 Mar 10;14(6):1434. doi: 10.3390/cancers14061434. Cancers (Basel). 2022. PMID: 35326583 Free PMC article.
Correlation of treatment outcome in sanger/RT‑qPCR KIT/PDGFRA wild‑type metastatic gastrointestinal stromal tumors with next‑generation sequencing results: A single‑center report.
Unk M, Bombač A, Jezeršek Novaković B, Stegel V, Šetrajčič Dragoš V, Blatnik O, Klančar G, Novaković S. Unk M, et al. Among authors: stegel v. Oncol Rep. 2022 Sep;48(3):167. doi: 10.3892/or.2022.8382. Epub 2022 Jul 29. Oncol Rep. 2022. PMID: 35904169 Free PMC article.
Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.
Krivokuca A, Dragos VS, Stamatovic L, Blatnik A, Boljevic I, Stegel V, Rakobradovic J, Skerl P, Jovandic S, Krajc M, Magic MB, Novakovic S. Krivokuca A, et al. Among authors: stegel v. Fam Cancer. 2018 Apr;17(2):179-185. doi: 10.1007/s10689-017-0022-x. Fam Cancer. 2018. PMID: 28685474
35 results